Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
Claudia Marchetti, Francesca De Felice, Anna Di Pinto, Alessia Romito, Angela Musella, Innocenza Palaia, Marco Monti, Vincenzo Tombolin, Ludovico Muzii, PierLuigi Benedetti Panici
Cancer Res Treat. 2018;50(3):768-776.   Published online 2017 Jul 19     DOI: https://doi.org/10.4143/crt.2017.141
Citations to this article as recorded by Crossref logo
Influence of the Clinical Nursing Pathway on Nursing Outcomes and Complications of Cervical Carcinoma Patients Undergoing Chemotherapy via PICC
Hongxia Tang, Li Gao, Yahui Li, Zhiqian Zhang
Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
Current and future direction in treatment of HPV-related cervical disease
Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
Journal of Molecular Medicine.2022; 100(6): 829.     CrossRef
Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy
Zhiyuan Xu, Li Yang, Qin Liu, Hao Yu, Longhua Chen, Claudia Marchetti
Journal of Oncology.2022; 2022: 1.     CrossRef
Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis
Lin Qi, Ning Li, Aimin Lin, Xiuli Wang, Jianglin Cong
Frontiers in Oncology.2022;[Epub]     CrossRef
Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
Jing Liu, Guyu Tang, Qin Zhou, Weilu Kuang
Radiation Oncology.2022;[Epub]     CrossRef
Pembrolizumab for advanced cervical cancer: safety and efficacy
Francesca De Felice, Elena Giudice, Giulia Bolomini, Maria Grazia Distefano, Giovanni Scambia, Anna Fagotti, Claudia Marchetti
Expert Review of Anticancer Therapy.2021; 21(2): 221.     CrossRef
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
Yifan Feng, Ye Wang, Yangqin Xie, Shuwei Wu, Yuyang Li, Min Li
BMC Cancer.2021;[Epub]     CrossRef
Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
Setareh Akhavan, Abbas Alibakhshi, Mahdieh Parsapoor, Abbas Alipour, Elahe Rezayof
BMC Cancer.2021;[Epub]     CrossRef
Macleayins A From Macleaya Promotes Cell Apoptosis Through Wnt/β-Catenin Signaling Pathway and Inhibits Proliferation, Migration, and Invasion in Cervical Cancer HeLa Cells
Chunmei Sai, Wei Qin, Junyu Meng, Li-Na Gao, Lufen Huang, Zhen Zhang, Huannan Wang, Haixia Chen, Chaohua Yan
Frontiers in Pharmacology.2021;[Epub]     CrossRef
Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
Lele Zang, Qin Chen, Xiaozhen Zhang, Xiaohong Zhong, Jian Chen, Yi Fang, An Lin, Min Wang
Cancer Management and Research.2021; Volume 13: 9391.     CrossRef
Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors
Xiaomin Zheng, Weiqian Guo, Jiangning Dong, Liting Qian
Magnetic Resonance Imaging.2020; 72: 159.     CrossRef
Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study
Guilan Xie, Ruiqi Wang, Li Shang, Cuifang Qi, Liren Yang, Liyan Huang, Wenfang Yang, Mei Chun Chung
BMC Cancer.2020;[Epub]     CrossRef
SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines
Xing Chen, Dongsheng Xiong, Liya Ye, Huichun Yang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Ruoran Mi
Cancer Chemotherapy and Pharmacology.2019; 83(4): 603.     CrossRef
Systemic therapy in cervical cancer: 30 years in review
Michalis Liontos, Anastasios Kyriazoglou, Ioannis Dimitriadis, Meletios-Athanasios Dimopoulos, Aristotelis Bamias
Critical Reviews in Oncology/Hematology.2019; 137: 9.     CrossRef
Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis
Meng Li, Mengyang Hu, Yuanjian Wang, Xingsheng Yang
European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 1.     CrossRef
Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study
Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong
International Journal of Clinical Oncology.2019; 24(11): 1440.     CrossRef
Immune check-point in cervical cancer
F. De Felice, C. Marchetti, I. Palaia, R. Ostuni, L. Muzii, V. Tombolini, P. Benedetti Panici
Critical Reviews in Oncology/Hematology.2018; 129: 40.     CrossRef